← Back to headlines
Organogenesis Shares Rise on PuraPlyAM Success in Diabetic Foot Ulcers
Organogenesis saw its shares rise following the successful application of its PuraPlyAM product in treating diabetic foot ulcers.
7 Apr, 10:50 — 7 Apr, 10:50
Sources
Showing 1 of 1 sources



